I am deeply honored to reconnect with Dr. Thomas Dayspring, who joined me in 2024 for an immensely popular five-part series. Dr. Dayspring is certified in internal medicine and clinical lipidology. He is a distinguished fellow of both the American College of Physicians and the National Lipid Association. 

Today, we have the first episode in a new series of conversations with Dr. Dayspring, in which he will share more of his perspective and answer more questions from listeners. In our discussion, we review the basics about cholesterol, triglycerides, and lipoproteins, exploring the factors that contribute to the development of cardiovascular disease, the significance of ApoB and Lp(a), and the risk factors for younger women. We also dive into the limitations of traditional allopathic medicines, and Dr. Dayspring shares his views on lipids, lipid changes in menopause, specific ways to address ApoB, some of the challenges associated with statin therapy, and more. 

Dr. Dayspring brings a wealth of experience and expertise to this discussion, and you are sure to find this series as invaluable as the last.

IN THIS EPISODE, YOU WILL LEARN:

Dr. Dayspring revisits the differences between cholesterol, triglycerides, and lipoproteins

What atherosclerosis is, and why it is concerning

Dr. Dayspring explains the structure and function of lipoproteins

The role of ApoB in lipoprotein particles and its significance in atherosclerosis

Some of the risk factors for lipid abnormalities in younger women

Lipid changes that occur as women transition from perimenopause to menopause 

Dr. Dayspring shares his take on statin therapy

Ways to address high ApoB

Dr. Dayspring’s suggested goals for ApoB therapy

Connect with Cynthia Thurlow  

Connect with Dr. Thomas Dayspring

On⁠ X⁠ (@Drlipid)

On⁠ LinkedIn⁠

⁠Journal Article: Atherosclerosis: Non-genetic influences on lipoprotein(a) concentrations⁠ 

⁠Journal of the American Heart Association: Trajectories of Blood Lipid Profiles in Midlife Women: Does Menopause Matter?⁠